Desmopressin  	Desmopressin  	 JJ	B-NP
parenteral  	parenteral  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VWD1 	VWD1 	 NNP	B-NP
,  	,  	 ,	O
VWD  	VWD  	 NNP	O
2A  	2A  	 NNP	O
and  	and  	 CC	O
thrombocytopathy  	thrombocytopathy  	 JJ	B-NP
Desmopressin  	Desmopressin  	 NNP	I-NP
( 	( 	 -LRB-	O
DDAVP 	DDAVP 	 NNP	B-NP
,  	,  	 ,	O
Minirin®  	Minirin®  	 CD	B-NP
parenteral 	parenteral 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
induces  	induces  	 VBZ	O
the  	the  	 DT	O
release  	release  	 NN	O
of  	of  	 IN	O
von-Willebrand  	von-Willebrand  	 JJ	B-NP
factor  	factor  	 NN	I-NP
from  	from  	 IN	O
endogenous  	endogenous  	 JJ	B-NP
stores 	stores 	 NNS	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
indicated  	indicated  	 VBN	O
in  	in  	 IN	O
von  	von  	 NNP	B-NP
Willebrand  	Willebrand  	 NNP	I-NP
disease  	disease  	 NN	I-NP
type  	type  	 NN	O
1  	1  	 CD	O
( 	( 	 -LRB-	O
VWD  	VWD  	 NNP	B-NP
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	B-NP
effectiveness  	effectiveness  	 NN	I-NP
of  	of  	 IN	I-NP
DDAVP  	DDAVP  	 NNP	I-NP
was  	was  	 VBD	O
tested  	tested  	 VBN	O
and  	and  	 CC	O
side  	side  	 NN	B-NP
effects  	effects  	 NNS	I-NP
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VWD  	VWD  	 NNP	B-NP
1 	1 	 CD	O
,  	,  	 ,	O
von  	von  	 NNP	B-NP
Willebrand  	Willebrand  	 NNP	I-NP
disease  	disease  	 NN	I-NP
type  	type  	 NN	O
2  	2  	 CD	O
( 	( 	 -LRB-	O
VWD  	VWD  	 NNP	B-NP
2 	2 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
thrombocytopathy  	thrombocytopathy  	 NNS	B-NP
( 	( 	 -LRB-	O
TCP 	TCP 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Subjects  	Subjects  	 NNS	B-NP
were  	were  	 VBD	O
analysed  	analysed  	 VBN	O
prior  	prior  	 RB	O
to  	to  	 TO	O
and  	and  	 CC	O
after  	after  	 IN	O
Minirin  	Minirin  	 NNP	B-NP
parenteral  	parenteral  	 FW	I-NP
infusion  	infusion  	 FW	I-NP
( 	( 	 -LRB-	O
0.4  	0.4  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
kg  	kg  	 JJ	I-NP
body  	body  	 NN	I-NP
weight  	weight  	 NN	I-NP
( 	( 	 -LRB-	O
b.w. 	b.w. 	 NNP	O
)  	)  	 -RRB-	O
over  	over  	 IN	O
60  	60  	 CD	O
minutes 	minutes 	 NNS	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
partial  	partial  	 JJ	B-NP
thromboplastin  	thromboplastin  	 JJ	I-NP
time  	time  	 NN	I-NP
( 	( 	 -LRB-	O
PTT 	PTT 	 NNP	B-NP
,  	,  	 ,	O
seconds 	seconds 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
ADP 	ADP 	 FW	B-NP
/ 	/ 	 FW	I-NP
epinephrine  	epinephrine  	 FW	I-NP
triggered  	triggered  	 FW	I-NP
platelet-function  	platelet-function  	 FW	I-NP
analyzer  	analyzer  	 FW	I-NP
( 	( 	 -LRB-	O
PFA-100 	PFA-100 	 NNP	B-NP
)  	)  	 -RRB-	O
occlusion  	occlusion  	 JJ	B-NP
time  	time  	 NN	I-NP
( 	( 	 -LRB-	O
seconds 	seconds 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
factor  	factor  	 NN	B-NP
VIII  	VIII  	 NNP	I-NP
activity  	activity  	 NN	O
( 	( 	 -LRB-	O
FVIII 	FVIII 	 NNP	B-NP
,  	,  	 ,	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
VWF  	VWF  	 NNP	B-NP
as  	as  	 IN	O
ristocetin  	ristocetin  	 JJ	B-NP
cofactor  	cofactor  	 JJ	I-NP
activity  	activity  	 NN	I-NP
( 	( 	 -LRB-	O
VWF 	VWF 	 NNP	B-NP
: 	: 	 :	O
RCo 	RCo 	 NNP	B-NP
,  	,  	 ,	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
VWF  	VWF  	 NNP	B-NP
antigen  	antigen  	 NN	O
( 	( 	 -LRB-	O
VWF 	VWF 	 NNP	B-NP
: 	: 	 :	O
Ag 	Ag 	 NNP	B-NP
,  	,  	 ,	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Side  	Side  	 NN	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
DDAVP  	DDAVP  	 NNP	I-NP
during  	during  	 IN	O
operative  	operative  	 JJ	B-NP
interventions  	interventions  	 NNS	I-NP
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
per  	per  	 IN	O
questionnaires  	questionnaires  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
±  	±  	 CD	O
standard  	standard  	 JJ	O
deviation  	deviation  	 NN	B-NP
dose  	dose  	 NN	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
165  	165  	 CD	O
patients 	patients 	 NNS	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
Minirin  	Minirin  	 NNP	B-NP
parenteral  	parenteral  	 NN	I-NP
administered  	administered  	 NNS	O
was  	was  	 VBD	O
0.37  	0.37  	 CD	O
±  	±  	 CD	O
0.02  	0.02  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
kg  	kg  	 CD	I-NP
b.w. 	b.w. 	 CD	I-NP
,  	,  	 ,	O
most  	most  	 RBS	O
often  	often  	 RB	O
upcoming  	upcoming  	 JJ	O
dental  	dental  	 JJ	B-NP
operations  	operations  	 NNS	I-NP
( 	( 	 -LRB-	O
57 	57 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
necessitated  	necessitated  	 JJ	O
testing 	testing 	 NN	O
.  	.  	 .	O
Coagulation  	Coagulation  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VWD  	VWD  	 NNP	B-NP
1  	1  	 CD	O
or  	or  	 CC	O
TCP  	TCP  	 NNP	B-NP
normalised  	normalised  	 NN	O
in  	in  	 IN	O
almost  	almost  	 RB	O
all  	all  	 DT	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
only  	only  	 RB	O
in  	in  	 IN	O
approximately  	approximately  	 RB	O
50 	50 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VWD  	VWD  	 NNP	B-NP
2  	2  	 CD	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Appraisal  	Appraisal  	 NN	O
of  	of  	 IN	O
effectiveness  	effectiveness  	 NN	O
of  	of  	 IN	O
Minirin  	Minirin  	 NNP	B-NP
parenteral  	parenteral  	 NN	I-NP
as  	as  	 IN	O
good  	good  	 JJ	O
was  	was  	 VBD	O
96 	96 	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
case  	case  	 NN	O
of  	of  	 IN	O
VWD  	VWD  	 NNP	B-NP
1  	1  	 CD	O
and  	and  	 CC	O
95  	95  	 CD	O
%  	%  	 NN	O
in  	in  	 IN	O
case  	case  	 NN	O
of  	of  	 IN	O
TCP 	TCP 	 NNP	B-NP
.  	.  	 .	O
During  	During  	 IN	O
minor  	minor  	 JJ	O
surgeries  	surgeries  	 NNS	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
23 	23 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
91 	91 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
no  	no  	 DT	O
complications  	complications  	 NNS	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
2  	2  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
9 	9 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
postoperative  	postoperative  	 JJ	B-NP
haemorrhages  	haemorrhages  	 NN	I-NP
without  	without  	 IN	O
need  	need  	 NN	O
for  	for  	 IN	O
further  	further  	 JJ	O
interventions  	interventions  	 NNS	B-NP
occurred 	occurred 	 VBD	O
,  	,  	 ,	O
but  	but  	 CC	O
83 	83 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
patients  	patients  	 NNS	O
reported  	reported  	 VBD	O
adverse  	adverse  	 JJ	O
reactions  	reactions  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
questionnaires 	questionnaires 	 NN	O
,  	,  	 ,	O
although  	although  	 IN	O
Minirin  	Minirin  	 NNP	B-NP
parenteral  	parenteral  	 NN	I-NP
was  	was  	 VBD	O
well  	well  	 RB	O
tolerated  	tolerated  	 VBN	O
by  	by  	 IN	O
all  	all  	 DT	O
patients  	patients  	 NNS	O
during  	during  	 IN	O
DDAVP  	DDAVP  	 NNP	B-NP
efficacy  	efficacy  	 NN	I-NP
tests 	tests 	 NNS	I-NP
.  	.  	 .	O
Desmopressin  	Desmopressin  	 NNP	B-NP
is  	is  	 VBZ	O
well  	well  	 RB	O
tolerated  	tolerated  	 JJ	O
and  	and  	 CC	O
affective  	affective  	 NN	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
VWD  	VWD  	 NNP	B-NP
1  	1  	 CD	O
and  	and  	 CC	O
thrombocytopathy 	thrombocytopathy 	 NN	B-NP
.  	.  	 .	O
